There is good news about the treatment of CCP virus. A biotechnology team at Yang Ming University of Transportation and Communications has used AI data to find an “old anti-inflammatory drug” that has not yet been named and has been shown to be 10 times more powerful than the most widely used antidote, raltegravir, in animal studies.
Good news for the treatment of COVID19. A biotechnology team from the National Yang Ming University of Transportation and Communications (Yang Ming Jiao Tong University) in the Republic of China has found four potential antidotes to inhibit the activity of the Chinese communist virus through big data from AI, and one of them, an “old anti-inflammatory drug” whose name has not yet been announced, has been shown to be 10 times stronger than the most widely used antidote at this stage in animal studies In animal studies, it has been proven that it is 10 times more powerful than the most widely used antidote, “Ridciclovir”. However, some scholars revealed that it has encountered difficulties in human trials and now hope to publish it in journals and apply for a patent as soon as possible, so that it can be put into actual medical treatment. The media is curious about the view of the command center? Zhuang Renxiang, the spokesman of the Command Center, said at the press conference on the Epidemic, “We are certainly optimistic” and hope that the domestic research can enter the stage of animal or human trials as soon as possible.
New breakthrough in COVID19 drug 10 times stronger than raltegravir
According to CTS, in addition to the anti-hepatitis C virus drug Boceprevir, the biotech team also announced another anti-hepatitis C virus drug Telaprevir, the anti-AIDS drug Nelfinavir, and an old anti-inflammatory drug (JMY206) whose name cannot be announced yet.
In particular, JMY206 may become the strongest COVID19 antidote, the university’s dean of the College of Biological Sciences Yang Jinmu said: “About 10 times better than Ridciclovir, toxicity is lower than it, the effect is better than it, the effect is better than it depends on the infiltration situation in the lungs, (experimental progress) to hamsters, hamsters are large rats.”
At present, the National Defense College of Medicine‘s P4 laboratory confirmed that this anti-inflammatory drug in animal experiments can prevent virus invasion and replication, but also to reduce fever and discomfort and other circumstances, can be expected to be the world’s first “multi-effect” antidote.
However, Dr. also said that there are still difficulties at this stage to be applied to humans, Yang Jinmu said: “We have tried to make contacts in other countries, but in fact there are some difficulties.”
Dr. Yang admits that academic teams around the world are competing to develop the most effective antidote, and Taiwan‘s first discovery of the drug’s multifunctional is gratifying, the next phase of the most important goal is to quickly publish, Yang said: “We will definitely publish, because we are hoping to target the better journals, because we have made the mechanism clear. “
This project is funded by the Ministry of Education‘s Ministry of Science and Technology and the National Institute of health and other relevant units to research, treatment of the virus revealed a glimmer of light, although this most clinically valuable oral drug, has not yet been officially used in the treatment, but is just around the corner.
Command Center Response
According to SETN, Chuang said that it is difficult to develop new drugs, and the international community tends to find potential drugs from old drugs, and the Yang Jiaotong University team has the technology to do chemical analysis and find four potential drugs from old drugs with big data within three months. The command center is optimistic about the future development.
Recent Comments